450 related articles for article (PubMed ID: 25823710)
1. FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.
Yan X; Chen J; Zhang C; Zhou S; Zhang Z; Chen J; Feng W; Li X; Tan Y
J Cell Mol Med; 2015 Jul; 19(7):1557-68. PubMed ID: 25823710
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice.
Yan X; Chen J; Zhang C; Zeng J; Zhou S; Zhang Z; Lu X; Chen J; Feng W; Li X; Tan Y
Cardiovasc Diabetol; 2015 Jun; 14(1):77. PubMed ID: 27391008
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.
Ye D; Wang Y; Li H; Jia W; Man K; Lo CM; Wang Y; Lam KS; Xu A
Hepatology; 2014 Sep; 60(3):977-89. PubMed ID: 24590984
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice.
Rusli F; Deelen J; Andriyani E; Boekschoten MV; Lute C; van den Akker EB; Müller M; Beekman M; Steegenga WT
Sci Rep; 2016 Jul; 6():30484. PubMed ID: 27470139
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of FGF21 on diabetes-induced male germ cell apoptosis is associated with up-regulated testicular AKT and AMPK/Sirt1/PGC-1α signaling.
Jiang X; Chen J; Zhang C; Zhang Z; Tan Y; Feng W; Skibba M; Xin Y; Cai L
Endocrinology; 2015 Mar; 156(3):1156-70. PubMed ID: 25560828
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 21 inhibition aggravates cardiac dysfunction in diabetic cardiomyopathy by improving lipid accumulation.
Chen C; Meng Z; Zheng Y; Hu B; Shen E
Exp Ther Med; 2018 Jan; 15(1):75-84. PubMed ID: 29375676
[TBL] [Abstract][Full Text] [Related]
9. TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes.
Dong B; Qi D; Yang L; Huang Y; Xiao X; Tai N; Wen L; Wong FS
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(6):H732-42. PubMed ID: 22842069
[TBL] [Abstract][Full Text] [Related]
10. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
11. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice.
Wu F; Wang B; Zhang S; Shi L; Wang Y; Xiong R; Pan X; Gong F; Li X; Lin Z
Clin Sci (Lond); 2017 Aug; 131(15):1877-1893. PubMed ID: 28559425
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 19 protects the heart from oxidative stress-induced diabetic cardiomyopathy via activation of AMPK/Nrf2/HO-1 pathway.
Li X; Wu D; Tian Y
Biochem Biophys Res Commun; 2018 Jul; 502(1):62-68. PubMed ID: 29778534
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway.
Zhang C; Huang Z; Gu J; Yan X; Lu X; Zhou S; Wang S; Shao M; Zhang F; Cheng P; Feng W; Tan Y; Li X
Diabetologia; 2015 Aug; 58(8):1937-48. PubMed ID: 26040473
[TBL] [Abstract][Full Text] [Related]
14. GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress.
Feng W; Lei T; Wang Y; Feng R; Yuan J; Shen X; Wu Y; Gao J; Ding W; Lu Z
Free Radic Biol Med; 2019 Jan; 130():128-139. PubMed ID: 30389499
[TBL] [Abstract][Full Text] [Related]
15. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
[TBL] [Abstract][Full Text] [Related]
16. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy.
Cheng Y; Zhang J; Guo W; Li F; Sun W; Chen J; Zhang C; Lu X; Tan Y; Feng W; Fu Y; Liu GC; Xu Z; Cai L
Free Radic Biol Med; 2016 Apr; 93():94-109. PubMed ID: 26849944
[TBL] [Abstract][Full Text] [Related]
20. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
